Yarrow Bioscience, Inc. (YARW) Profit Margins
Over the twelve months to 2026-06-30, Yarrow Bioscience, Inc. (YARW) had operating margin -4134.6%, net margin -3881.5%, free cash flow margin -3513.1%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
YARWYarrow Bioscience, Inc.Follow YARW — free
—
Price chart with a free account
- Market cap
- 51.4M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2018 Dec 18 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | 93.4% | -259.6% | — | — | — | — | — | |
| Operating margin | -703.9% | -1203.0% | -4179.5% | -7189.7% | -6900.5% | -8710.0% | -5219.1% | -4134.6% | |
| Net margin | -697.0% | -1217.4% | -7876.4% | -4865.8% | -6710.4% | -7950.9% | -4646.1% | -3881.5% | |
| FCF margin | -650.7% | -653.5% | -6054.5% | — | — | -6804.2% | -5811.2% | -3513.1% |
USD millions · SEC XBRL
Yarrow Bioscience, Inc. — questions
- What is Yarrow Bioscience, Inc.'s operating margin?
- -4134.6% over the twelve months to 2026-06-30.
- What is Yarrow Bioscience, Inc.'s net profit margin?
- -3881.5% over the twelve months to 2026-06-30.
Every figure on this page comes from Yarrow Bioscience, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.